Who invested in Envisagenics

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIBiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$27Mraised across 2 rounds since 2017, from 2 sources

$2.3MSeed$25MSeries B

Latest round: Series B, $25MJun 2024
Step-upi: 11.1×
Investors: 4

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2018201920202021202220232024

$2.3MSeed$25MSeries B

First round: Seed, $2.3M
Biggest round: $25M
Between rounds: 6.5 years

The rounds

Jun 2024
Series B$25M3 new
Source recorded
Nov 2017
Seed$2.3M1 new
- Dynamk Capital
Reported by FinSMEsSEC filing: $2.5M sold, first sale Mar 2017

Founders and team

From the SEC filings it signed: 3 on the team.

Maria Luisa PinedaCEOi
Martin Luisa AkermanCTOi
Bradley S. HarrisSecretaryi

On the board, as filediAlan S. RoemerGrant Luisa Verstanding

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2017Series B2024

SV Angel

Madrona Venture Group

National Institutes of Health

Dynamk Capital

Everyone who backed them

SV AngelVC firm1round

Madrona Venture GroupVC firm1round

National Institutes of HealthGovernment1round

Dynamk CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 4 firms list Envisagenics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.